Ingredient or product comparison
GHK-Cu vs Minoxidil and Finasteride for TE Recovery
Most patients encountering telogen effluvium are prescribed minoxidil (Rogaine) or finasteride (Propecia). Neither of which addresses the root cause of TE. Minoxidil is a vasodilator that increases blood flow to follicles but does not influence the hormonal or
This source-based comparison does not add ratings or recommend a winner.
- Most patients encountering telogen effluvium are prescribed minoxidil (Rogaine) or finasteride (Propecia). Neither of which addresses the root cause of TE. Minoxidil is a vasodilator that increases blood flow to follicles but does not influence the hormonal or metabolic signals that triggered telogen entry. Finasteride inhibits 5-alpha reductase (blocking DHT conversion) and is effective for androgenetic alopecia but irrelevant for TE caused by stress, thyroid dysfunction, or nutritional deficiency.
- GHK-Cu studied in telogen effluvium contexts works through a fundamentally different pathway. It does not dilate vessels or block hormones. It directly stimulates dermal papilla cells to resume anagen signaling. This makes GHK-Cu particularly suited for acute TE (postpartum, post-surgery, telogen after fever or crash dieting) where the follicles are intact but metabolically suppressed.
- GHK-Cu
- Dermal papilla cell proliferation via TGF-beta and VEGF upregulation
- High. Directly addresses follicle dormancy at cellular level
- 8–12 weeks visible regrowth
- Preclinical (in vitro validated, limited human RCTs)
- Minoxidil 5%
- Vasodilation increases nutrient delivery to follicles
- Moderate. Supportive but does not reverse metabolic suppression
- 12–16 weeks visible regrowth
- FDA-approved for androgenetic alopecia (off-label for TE)
- Finasteride 1mg
- Inhibits 5-alpha reductase, reducing DHT-mediated miniaturization
- Low. Irrelevant unless TE is compounded by androgenetic alopecia
- 16–24 weeks visible regrowth
- FDA-approved for androgenetic alopecia only
- Platelet-Rich Plasma (PRP)
- Growth factor delivery from autologous platelets
- High. Similar growth factor signaling to GHK-Cu
- Established clinical use (dozens of RCTs)
- Professional Assessment
- GHK-Cu and PRP target the same biological mechanisms but via different delivery routes. GHK-Cu offers peptide precision without the procedural cost or discomfort of PRP injections. Minoxidil can be stacked with GHK-Cu. Finasteride is unnecessary unless androgenetic alopecia coexists.